SUPERNUS PHARMACEUTICALS, INC. (SUPN) Free cash flow 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$46.0MFY2025 · since FY2016: $65.2M → $46.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $46.0M | -73.1% |
| FY2024 | $171.2M | +54.9% |
| FY2023 | $110.5M | -5.1% |
| FY2022 | $116.4M | — |
| FY2020 | $134.9M | -3.9% |
| FY2019 | $140.4M | +9.6% |
| FY2018 | $128.1M | +13.8% |
| FY2017 | $112.6M | +72.7% |
| FY2016 | $65.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice